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Abstract
Vaccine efficacy has often been studied from the viewpoint of individual direct clinical protection. For several vaccines,
a decrease in pathogen shedding in vaccinated animals has also been documented, which suggests that transmission
between individuals has the potential to be reduced. In addition, vaccination induces an immune response in the host
potentially decreasing susceptibility to infection in comparison with immunologically naïve animals. As a collective
result of individual vaccinations, vaccine programmes generally have a wider impact on pathogen diffusion at the
population scale. Beyond the individual protection conferred by mass vaccination campaigns, the indirect protection
of non-immune individuals in contact with vaccinated ones also contributes to controlling pathogen spread at the
population scale; a phenomenon known as herd immunity.
Pathogen spread within pig populations is strongly related to the required vaccine coverage at the population level and
to pathogen characteristics in terms of diffusion (R0). Before setting up vaccination programmes, it is therefore necessary
to have quantitative knowledge on vaccine efficacy as regards transmission reduction. These data can be obtained by
carrying out experimental studies or observational protocols in real conditions. These quantitative data have mainly been
estimated for major infectious diseases which have now been eradicated. A great gap in knowledge has however been
identified for enzootic diseases which are daily impacting the swine sector as well as for the source of variation
responsible for a decrease in vaccine efficacy as compared to assessments obtained in experimental conditions.
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Background
The main pursued effect of vaccines used in pig produc-
tion and generally in animal production, is the individual
direct protection. The main expected impact resides in a
significant decrease of the clinical signs associated with
the infection that the animals are vaccinated against. The
decrease of pathogen shedding in vaccinated animals has
also been documented for several vaccines. However, it is
well established that the majority of vaccines used in
human and veterinary medicine confer only partial protec-
tion, thus the risk of infection remains [1]. All vaccines
used in pig production can be considered as such.
The effect of vaccination programmes at the population
scale is the result of a collective impact of individual vacci-
nations on the transmission of the infection within the
population. While the individual protection is the target
objective of mass vaccination programmes (vaccination of
the whole population), the global effect at the population
scale also contributes indirectly to individual protection
according to the “herd immunity” concept. The impact at
the population scale of a vaccination programme depends
on three main factors. First, the epidemiology of the
pathogen and its transmission potential of the infectious
agent, which is generally summarized by the basic
reproduction number denoted R0 . This parameter corre-
sponds to the average number of infected individuals
produced by a typical infectious individual during its whole
period of infectiousness in a fully susceptible and large
population. Second, the ability of the vaccine to modify the
contribution of the individual to the transmission of the
infection within the population, which can be summarized
by the vaccine efficacy as regards transmission. This charac-
teristic combines the reduction of susceptibility to infection
through a certain level of individual direct protection and
the effect of vaccine on the reduction of infectivity (ability
to transmit the pathogen). Susceptibility is defined by the
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probability of infection in vaccinated animals when in
contact with shedding individuals while infectivity is
represented by the probability of seeding new infections by
shedding animals. For this latter parameter, vaccination can
result in the decrease of the duration of pathogen transmis-
sion and/or of the quantity of pathogen shed by the host.
Third, the vaccination programme and particularly the
vaccine coverage within the population [2]. This last
characteristic is linked to the reproduction number specific
to the pathogen.
From a general point of view, the higher the R0 , the
more difficult the pathogen to eradicate. For infection
eradication, the effective reproduction number within the
vaccinated population denoted R must be brought below
1. It corresponds to the modification of pathogen trans-
mission because of an efficient immunization of a propor-
tion P of pigs within the population. Indeed, let x = 1 − P
correspond to the non-immune fraction in the population,
then R = R0x should get lower than 1 to reach eradication.
Otherwise stated, the fraction of vaccinated population
should exceed the critical vaccination coverage defined by
P0 ¼ 1− 1R0 . This relation shows that eradication of a
pathogen that has a high R0 requires extensive vaccine
coverage (Fig. 1). Considering a full vaccine efficacy as
regards the infectious agent, it follows that the fraction of
the vaccinated population cannot get infected. In conse-
quence, the number of infectious individuals is reduced,
leading to a global decrease of the force of infection
exerted on non-vaccinated animals. Each vaccinated indi-
vidual contributes therefore to the global protection of the
population which is known as “the herd immunity” [3].
This relationship between the vaccine coverage and R0
allows the prediction of the benefit of vaccination in terms
of reduction of the number of infectious individuals when
the infectious process tends towards an equilibrium and
according to the vaccine coverage which can be imple-
mented considering economic and technical constraints
(e.g. partial vaccination of the herd as the only affordable
strategy). For an infectious agent such as Porcine Circo-
virus type 2 (PCV2) or a European strain of the Porcine
Reproductive and Respiratory Syndrome virus (PRRSv),
for which an average reproduction number of 5 has been
estimated [4, 5], a vaccine coverage of 80% of the whole
population should theoretically allow pathogen eradica-
tion. However, an effective vaccine coverage pE of 50% of
the population would lead to a reduction of the number of
infected individuals by 62% Pe=P 0 100
 
.
One of the key factors to be accounted for in the field is
that the protection conferred by the large majority of vac-
cines does not fully prevent infection. In this case, the crit-
ical threshold applies to the fraction of the population that
should be immunized (according to the level of
immunization conferred by the vaccine). A partial protec-
tion can reside in different causes: the vaccine can be able
to reduce the susceptibility of pigs to the infection (decreas-
ing the risk of getting infected); it can also decrease patho-
gen transmission once the pig is infected, or accelerate the
elimination of the pathogen, hence reducing the duration of
shedding. These vaccines, providing a limited protection
from an epidemiological point of view, are generally called
“leaky vaccines”. In this case, the critical vaccine coverage
can be defined considering a reproduction number specific
Fig. 1 Relationships between the vaccine coverage within the population (proportion of the population to be immunized) and the R0 value
(particular case of vaccine conferring a “perfect” protection)
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to the vaccinated population, Rv , parameter corresponding
to the number of secondary cases produced by an infectious
individual when the whole population is vaccinated. The
critical threshold for vaccine coverage becomes therefore
Vc ¼ R0−1R0−Rv
The eradication of the infection requires Rv to be lower
than 1. In Fig. 2, it appears that when a vaccine only induces
partial protection to the animals, the eradication remains
possible whenever Rv <1, but would require the vaccination
of the entire population when Rv gets close to 1.
Building control programmes based on vaccine tools at
the population level requires quantitative data on the ability
of vaccines to decrease pathogen transmission within the
target population. The following sections will aim at (i)
describing the methodological approaches available for the
estimation of the reproduction number in vaccinated
population through the comparison of experimental and
observational approaches, (ii) summarizing existing data for
the different pig pathogens and their limitations. Applied
consequences of these theoretical aspects are further
confronted to the different vaccine practices and protocols
usually set up in pig farms.
Assessing the impact of a vaccine on pathogen
transmission
In the objective of using a vaccine as an epidemiological
tool for disease eradication or at least reducing the impact
of an infection on the population, it is pivotal that the vac-
cine could significantly reduce the pathogen spread within
the population. Classical studies based on the principle of
vaccination followed by a challenge are not sufficient to
produce information on pathogen transmission (how the
pathogen spreads and at which rate), given the fact that
these studies focus on infection characteristics at the indi-
vidual level. It is therefore necessary to study how the
pathogen spreads within a vaccinated population and
which factors are likely to modify transmission. Pure
qualitative studies describing the transmission of the
pathogen to sentinel susceptible pigs do not inform on (i)
the extent of the transmission process and (ii) the signifi-
cance of observed differences in terms of transmission be-
tween vaccinated and non-vaccinated populations. These
specific questions can only be addressed through quantita-
tive estimation of the transmission potential between
hosts. Both experimental studies in controlled conditions
and observational studies in real conditions can be used to
these ends. The specificity of studied infectious processes
relies on dependent incidences of infections within differ-
ent groups belonging to the same population, leading to
non-linear dynamic infectious processes. In this specific
case, non-linear mathematical models are useful to formu-
late hypothesis on mechanisms and types of transmission
involved, understand the epidemiological processes and
assess the potential efficacy of control measures [6].
Experimental assessment: transmission trials
The efficacy of a vaccine regarding the reduction of trans-
mission of an infectious agent must be assessed within
homogeneous groups, which implies that all the pigs of a
group, including sentinel ones, should be vaccinated,
whereas pigs from the control group are not. Pigs belonging
to the same group are assumed to be comparable, i.e. with
a similar susceptibility to infection and a comparable infec-
tiousness once infected. Moreover, they must move freely
among the group to verify the hypothesis of homogenous
contacts between pigs within groups. The transmission rate
cannot be estimated properly through the involvement of
Fig. 2 Evolution of the vaccine coverage (proportion of the population to be vaccinated) according to the basic reproduction number R0 and for
different values of Rv (effective reproduction number when the whole population is vaccinated)
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pigs of heterogeneous statuses within experimental groups
(e.g. mingling of fully susceptible and vaccinated animals
within a group of vaccinated and further infected pigs).
Vaccination generally reduces both the susceptibility to in-
fection and the level of pathogen shedding once infected.
Inoculating non vaccinated pigs within a group of vacci-
nated contact pigs can potentially lead to an extended shed-
ding of the pathogen because non vaccinated and
inoculated pigs are more infectious than vaccinated and
further inoculated pigs. The other case corresponding to
non-vaccinated pigs in contact with vaccinated and inocu-
lated pigs can likely lead to an extended diffusion owing to
a higher susceptibility to infection of contact pigs.
Three estimation methods are described in the litera-
ture to analyse such data. The principle of the statistical
analysis of experimental transmission data can be based
on the final state of the epidemic process observed at
the end of the experiment [7]. The so-called « final size
» algorithm (FS) consists in calculating probabilities of
each possible final state [8]. Hence, for an experimental
trial involving five susceptible individuals and five infec-
tious pigs (S0 = 5, I0 = 5), the whole possible observations
when the infectious process ends are (S, I) ∈ {(5, 0), (4,
0), (3, 0), (2, 0), (1, 0), (0, 0)}. To each of these states cor-
responds a probability dependent on the reproduction
number R0. This number is estimated by confronting the
results of the experiment with the associated probabil-
ities by the method of the maximum likelihood. The
transient state algorithm (TS) relies on the other hand
on a time-continuous version of the previous one and
requires complex calculations because of its recursive-
ness and can therefore be used only for trials involving a
limited number of animals [8].
As previous approaches, the estimation method based on
the martingale formula proposed by Becker [9] requires to
provide the initial number of susceptible and infectious, as
well as the final state of the system, i.e. the number of
remaining susceptible animals at the end of the experiment.
This method is preferably used for large populations and
therefore less adapted to experimental conditions. However,
when all the replications of a transmission experiment re-
sult in the infection of all initially susceptible animals, esti-
mations from the two first algorithms tend to infinity.
Conversely, the martingale method allows an estimation of
R0 by evaluating the loss of infectiousness accounting for
the remaining duration of shedding of infectious individuals
after the infection of the last contact pig.
Another approach is based on the analysis of the kinet-
ics of new infections occurring among sentinel pigs during
the experiment. In this particular case, the estimation of
the reproduction number is deduced from the independ-
ent estimation of the transmission rate, commonly de-
noted β, and from the duration of infectiousness 1/σ: R0
= β/σ. The approach is more dynamic and fully takes
advantage of the longitudinal follow up of pigs during the
experiment. Becker [9] proposed the use of generalized
linear models (GLM) to estimate the transmission rate of
an infectious agent within a population. This approach al-
lows accounting for heterogeneity regarding both infectiv-
ity of infectious individuals and susceptibility for sentinel
pigs. The limitations of the GLM approach are mainly due
to the impossibility to account for a specific contact struc-
ture (e.g. within- and between-pen [10]). The statistical
analysis of these data requires to write explicitly and to
maximize the likelihood function linking the theoretical
model and observed data. The duration of the infectious
period is often assessed from virological and serological
individual data using parametric survival models. These
studies require a close individual follow-up of pigs with
frequent monitoring of their status in order to determine
precisely the number of new infections occurring between
two sampling times. The protocol (number of pigs being
inoculated, number of contact pigs, and interval between
two samplings) must be determined according to the
knowledge available on the transmission characteristics of
the pathogen. For example a pathogen like influenza virus
which can transmit very fast and efficiently on a very short
period of time (5–6 days) would require a frequent sam-
pling (daily or more) compared to other pathogens having
a prolonged duration of shedding with a daily transmis-
sion rate which is much more lower (PRRS virus, PCV2).
Observational approaches in real conditions
The main limitations of experimental studies are the poten-
tial extrapolation of results to field conditions. In experi-
mental conditions, the pure infectious process is generally
reproduced (without any co-infections, in small-size,
homogeneous and low density population). For these rea-
sons, estimations should be considered with care before
transposing them to real situation with systematic co-
infections. Consequently, observational studies carried out
in real conditions constitute an ultimate step in vaccine
evaluation. These studies are often based on a longitudinal
follow-up of infection chains using a descriptor to assess
the evolution of infectious individuals. Serology is generally
used, because it is often the only option in terms of cost
and feasibility for large scale studies in farms where large
populations are sampled. However, the use of serology re-
quires differentiating antibodies markers of a past exposure
to the pathogen from potential antibodies induced by vac-
cination. This is only affordable when marked vaccines are
used (deleted or allowing Differentiation between Infected
and Vaccinated Animals [DIVA vaccines]) like Aujeszky’s
disease vaccines. By studying observed infection chains
based on seroconversion against gE protein within sow
herds vaccinated every 4 months, only minor outbreaks
were observed in a study carried out in The Netherlands,
although susceptible animals were regularly introduced into
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the herds. In this study, the estimated reproduction number
R was 0.7 within these vaccinated populations [11]. The
objective of another field study, also carried out in The
Netherlands, was to compare two pseudorabies virus
vaccination schemes in fattening pigs for a better control of
the infection: a single injection around 14 weeks of age
versus two injections at 11 and 15 weeks of age [12]. The
authors, used observed seroconversion data against gE pro-
tein to estimate the reproduction number using the same
approach as described for transmission experiments, i.e. a
stochastic SIR model representing infection chains leading
to a distribution of epidemic size at the end of the infec-
tious process (frequency of pigs having anti gE antibodies
at the end of fattening). By using these data, the authors
showed that double vaccination decreased the reproduction
number from 3.5 (single vaccination) to 1.5 (double) with-
out leading to total eradication (R > 1). Discrepancies be-
tween field and experimental studies can reside in different
factors such as the status of the animal at vaccination time,
non-properly performed vaccination in field conditions,
bioclimatic factors, other concurrent infections, etc.…
Available data on quantification of the
transmission of pathogens within a pig population
A summary of data available on the evaluation of the effi-
cacy of vaccines as regards the reduction of transmission of
main pathogens involved in pig production is presented in
Table 1. The most numerous studies have been carried out
on Aujeszky’s disease and classical swine fever because of
the paramount importance of such data to set up eradica-
tion plans for these notifiable diseases. The majority of
studies have been carried out in experimental conditions,
except for Aujeszky’s disease for which several studies
aiming at vaccine evaluation in field conditions have been
set up at the end of the 90’s. Generally, a good agreement
between results from different published studies has been
observed showing either a good ability of vaccines to sig-
nificantly decrease the transmission rate (with sometimes
an expected reproduction number significantly lower than
1 in experimental conditions for Aujeszky’s disease, classical
swine fever or PRRS); or the absence of effect of vaccin-
ation on transmission (Mycoplasma vaccines). Available
data are very useful to incorporate parameter estimations
to epidemiological models set up to assist decision makers
in risk management [13]. However, differences between es-
timates obtained in experimental and real conditions sug-
gest that the effect of vaccines can potentially be modulated
by complex interactions between risk factors such as the
viral strain, contact heterogeneity within the population,
co-infections or husbandry practices. To further explore
these complex interactions, more experimental studies
would be required to evaluate the effect of vaccination on
pathogen transmission in presence of co-infections, espe-
cially because numerous pathogens of importance for pig
production are more involved in syndromes such as the
Porcine Respiratory Disease Complex (PRDC) than in pure
monofactorial diseases.
Source of variation of vaccine efficacy and
practical consequences on vaccination protocols
The theoretical efficacy of vaccines as regards pathogen
transmission can be considerably decreased under the
influence of several factors. The identification of these
critical factors is of importance for an optimal use of
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[33] 1 Decrease of
infectiousness only
/ Experimental study Separate evaluation of susceptibility
and infectiousness
PRRSv [17, 34, 35] 3 Significant reduction
of transmission
Good Experimental studies Good results with vaccine and
challenge strains belonging to
the same genotype
Influenza [36] 1 Significant reduction
of transmission
/ Experimental study Significant reduction of
transmission even with an
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PCV2 [5] 1 Significant reduction
of transmission
/ Experimental study Evaluation with a challenge strain
heterologous (2b) to the vaccine
strain (2a)
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vaccines in farms and the adaptation of the correspond-
ing protocol. Moreover, the vaccination scheme in farms
must be established considering the main goal of vaccin-
ation: is it targeted for piglet protection in their young
age to reduce virus or bacteria propagation at that stage?
Is the objective to limit pathogen circulation in the re-
productive herd which constitutes a permanent reservoir
and source of reinfection? Or is it to head towards a glo-
bal eradication at the herd level?
We will examine consecutively in this part factors lim-
iting vaccine efficacy as regards pathogen transmission
to be considered in vaccination programmes definition
as well as in the adaptation of protocols, consistently
with the main goal which is pursued.
Factors related to vaccine efficacy decrease
Specificities of vaccination in pig production reside in
the immunization of young animals when they generally
still have high levels of maternally derived antibodies
against the pathogen when the latter is settled enzooti-
cally within the herd or when the breeders are regularly
vaccinated against this pathogen. A recent experiment
showed that the PRRSv post-vaccine humoral and cellu-
lar response were considerably affected in piglets having
high levels of neutralizing maternally-derived antibodies
at vaccination time [14]. Conversely to piglets without
any neutralizing antibodies at vaccination time and evi-
dencing a vaccine viremia as soon as 2 weeks post-
vaccination, a rapid gamma interferon response and a
fast seroconversion 7 days post-vaccination, piglets with
high levels of neutralizing antibodies did not show any
immune response following vaccination or a weak and
delayed one (after 8 weeks post-vaccination). Similarly to
results available for Aujeszky’s disease virus [15] or clas-
sical swine fever [16], other supplementary studies
would be required to evaluate if this impaired immune
response in vaccinated animals decreases the protection
level of the vaccine and the theoretical impact it has on
transmission reduction [17].
Beside this interference between maternally derived
antibodies and vaccination, several diseases can be verti-
cally transmitted and are susceptible to lead to viremic
piglets at birth (PCV2, PRRSv for example). Vaccination
against these infections is generally implemented at wean-
ing, at 3 or 4 weeks of age, several piglets can therefore be
vaccinated while being viremic in unstable herds (active
circulation of the virus in the sow herd). Consequences of
vaccinating a viremic piglet are not well known but it is
likely that the immune system challenged by the concur-
rent infection would not be in the best situation to cope
with the vaccine challenge and that the effect of vaccine
would therefore be considerably reduced or abolished.
Under certain circumstances (modified live vaccine), po-
tential deleterious consequences should be also considered
in case of simultaneous “co-infection” between the wild
and the modified live vaccine strain possibly leading to
reassortment events.
The influence of other circumstances on the quality of
the post-vaccine immune response such as co-infections
by different pathogens or the existence of bad environ-
mental or rearing conditions, are not well known and
would deserve to be better explored. Conversely, it has
been shown that some feed contaminants (mycotoxins)
could considerably decrease the quality of the immune
response following vaccination such as the one imple-
mented against PRRSv [18].
Adaptation of vaccination scheme to the objective
Vaccination programmes are established in pig produc-
tion according to the main goal which can be different
according to the infectious agent and/or the sanitary sta-
tus of the farm. Several vaccines only target breeders in
order to protect against the reproduction disorders in-
duced by the infection (case of porcine parvovirus for
example). Other vaccines are both used in breeders and
growing pigs. In this latter case, vaccination of young
piglets aims at its direct protection against the exposure
to targeted infectious agents during the growing part of
the pigs (PRRSv, PCV2, Mycoplasma vaccinations). Vac-
cination of breeders is also often implemented to confer
a certain level of specific immunity to piglets via the
transfer of colostral immunity. Vaccination scheme con-
sists in this case in boost injections at the end of gesta-
tion in sows to trigger the transfer of colostral immunity
to the offspring (flu vaccination, PRRSv, PCV2, colibacil-
losis…). The objective in this case is a clinical protection
of piglets during the lactation phase. However this pas-
sive immunity can also modify the propagation of patho-
gens in piglets young age. In the case of swine flu, it has
been shown recently in a transmission experiment in-
volving piglets born to vaccinated or non-vaccinated
sows that the presence of maternally derived antibodies
in piglets significantly decreased the virus transmission
but not enough to block its propagation within the
population. Moreover, the transmission intensity in this
immunized population born to vaccinated sows was slo-
wed down, increasing the total duration of the infectious
process within the population and enhancing potentially
the enzootic persistence of the virus in the farm [19, 20].
When implementing vaccination programmes in farms,
the consequences of the vaccination scheme in terms of
pathogen spread should also be considered, especially if the
objective must go beyond the only reduction of the clinical
impact of the infection. The most commonly practiced vac-
cination scheme is the “batch to batch” programme consist-
ing in the injection of the vaccine at a specific physiological
status with a regular booster at every cycle to protect the
sow and/or the offspring via colostral immunity. Because of
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batch-based rearing of the sow herd, all the batches are not
synchronized in terms of immune response with an in-
crease of immunity after each boost and a progressive
waning of immunity in the following months. At a specific
time, the level of immunity between batches is extremely
heterogeneous and this heterogeneity is permanent with
time, which suggests that the vaccination coverage at the
population level never reaches 80% (Fig. 3). The so-called
“mass” or “blanket” vaccination programmes resides in the
principle of a boost vaccination on the overall population
synchronized in time. This kind of protocol tends to
provide a larger homogeneity in terms of immunity at the
global population scale leading to a higher vaccination
coverage with time. However, if the objective is also to pro-
tect piglets via colostral immunity, the situation in terms of
expected level of passive immunity is much more heteroge-
neous than in the context of “batch to batch” vaccination.
Conclusions
Vaccines can be used far beyond the only objective of con-
ferring a clinical protection to the vaccinated population.
They can also constitute powerful tools for disease control
in animal populations as demonstrated in the past for
Aujeszky’s disease or classical swine fever. However, this effi-
cacy must be evaluated through specific experimental or ob-
servational studies which can provide quantitative estimates
of the impact of vaccination on pathogen spread within a
population. The examination of available quantitative data
on vaccine efficacy towards transmission evidenced an im-
portant lack of information for several pathogens of import-
ance in pig production with only few experimental studies.
Moreover, pure experimental assessment can represent im-
portant limitations in data extrapolation to field conditions
and several discrepancies have been shown between experi-
mental and field assessment such as for Aujeszky’s disease
for example. Several variation sources of vaccine expected
efficacy have been shown but the pivotal role of interactions
between pathogens in case of co-infections still need to be
examined in details. Vaccination practices in veterinary
medicine should be more and more considered at the popu-
lation scale and accounting for the main objective pursued.
If experimental studies cannot fully answer to all these ques-
tions, this is because of multiple factors potentially modify-
ing the efficacy of vaccines in real conditions related to herd
characteristics, biosecurity and husbandry practices. Al-
though the analysis of experimental or field data provides
important general insights on the infectious processes, herd-
specific conditions have to be considered to adapt control
measures to each specific epidemiological situation.
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